HomeURGN • NASDAQ
add
Urogen Pharma Ltd
Previous close
$24.28
Day range
$22.51 - $24.65
Year range
$3.42 - $29.98
Market cap
1.08B USD
Avg Volume
1.21M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 27.48M | 9.04% |
Operating expense | 51.59M | 28.03% |
Net income | -33.35M | -40.87% |
Net profit margin | -121.34 | -29.18% |
Earnings per share | -0.69 | -25.45% |
EBITDA | -26.40M | -51.08% |
Effective tax rate | 3.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 127.03M | -49.10% |
Total assets | 185.05M | -38.71% |
Total liabilities | 300.45M | 8.69% |
Total equity | -115.41M | — |
Shares outstanding | 46.81M | — |
Price to book | -9.83 | — |
Return on assets | -34.77% | — |
Return on capital | -281.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -33.35M | -40.87% |
Cash from operations | -42.27M | -52.80% |
Cash from investing | 31.40M | 129.41% |
Cash from financing | 8.27M | -79.11% |
Net change in cash | -2.60M | 97.26% |
Free cash flow | -22.59M | -24.77% |
About
Founded
2004
Headquarters
Website
Employees
287
